Administracin: Oral, cpsula intacta
Typical Clinical Ranges Loading Phase: 25 mg per week (subcutaneous injection) for 46 weeks Maintenance Phase: 2 mg every 12 weeks after the loading period Key Considerations Personalization: Dosage should be adjusted based on individual symptoms, sensitivities, and treatment response
PubMed laboratory research record [PMID: 4321506] PubMed record related to this compound for laboratory literature review
Yes psychological stress is a well-documented vitiligo trigger
Contraindicated in patients with a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia Syndromes (MEN 2) Consult your healthcare provider if you have a history of pancreatitis, as the medication may increase risk Serious side effects may involve hypoglycemia, kidney issues, or allergic reactions 1,5 Not suitable for individuals with type 1 diabetes or diabetic ketoacidosis Medication interactions may occur with those on insulin, oral diabetes medications, oral contraceptives, and blood thinners
[] This conclusion is consistent with findings from different, more extensive trials that indicated NACs benefits took time to manifest and were not significantly different after 8 weeks of treatment
